| Literature DB >> 21371538 |
Leah Grossman1, Adam Stewart, Siddharth Gaikwad, Eli Utterback, Nadine Wu, John Dileo, Kevin Frank, Peter Hart, Harry Howard, Allan V Kalueff.
Abstract
Piracetam, a derivative of γ-aminobutyric acid, exerts memory-enhancing and mild anxiolytic effects in human and rodent studies. To examine the drug's behavioral profile further, we assessed its effects on behavioral and endocrine (cortisol) responses of adult zebrafish (Danio rerio)--a novel model species rapidly gaining popularity in neurobehavioral research. Overall, acute piracetam did not affect zebrafish novel tank and light-dark box behavior at mild doses (25-400mg/L), but produced nonspecific behavioral inhibition at 700mg/L. No effects on cortisol levels or inter-/intra-session habituation in the novel tank test were observed for acute or chronic mild non-sedative dose of 200mg/L. In contrast, fish exposed to chronic piracetam at this dose performed significantly better in the cued learning plus-maze test. This observation parallels clinical and rodent literature on the behavioral profile of piracetam, supporting the utility of zebrafish paradigms for testing nootropic agents.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21371538 DOI: 10.1016/j.brainresbull.2011.02.008
Source DB: PubMed Journal: Brain Res Bull ISSN: 0361-9230 Impact factor: 4.077